Autologous bone marrow-derived MSCs engineered to express oFVIII-FLAG engraft in adult sheep and produce an effective increase in plasma FVIII levels is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL130856, HL135853, HL14868
National Institute of Biomedical Imaging and Bioengineering
Grant: 2T32EB014836-06A
NIBIB NIH HHS
Grant: T32 EB014836
NHLBI NIH HHS
Grant: R01 HL135853
NHLBI NIH HHS
Grant: R01 HL130856
National Institutes of Health
Grant: 5T32EB014836-10
Studies in Translational Regenerative Medicine
National Institutes of Health
Grant: 5R01HL135853-02
Prenatal Cell and Gene Therapy for Hemophilia A
National Institutes of Health
Grant: 1R01HL130856-01A1
Postnatal Cell-Based Therapies for Hemophilia A
Howard Hughes Medical Institute
Howard Hughes Medical Institute
FWCI
0.44
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals